• bitcoinBitcoin(BTC)$77,134.000.06%
  • ethereumEthereum(ETH)$2,544.043.38%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$724.511.86%
  • rippleXRP(XRP)$1.360.65%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$101.291.97%
  • tronTRON(TRX)$0.336615-0.81%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.030.43%
  • zcashZcash(ZEC)$1,174.183.86%
  • HyperliquidHyperliquid(HYPE)$80.871.26%
  • dogecoinDogecoin(DOGE)$0.0845091.19%
  • RainRain(RAIN)$0.015650-1.77%
  • USDSUSDS(USDS)$1.000.00%
  • moneroMonero(XMR)$513.980.36%
  • whitebitWhiteBIT Coin(WBT)$80.350.72%
  • chainlinkChainlink(LINK)$11.650.15%
  • leo-tokenLEO Token(LEO)$9.16-0.30%
  • cardanoCardano(ADA)$0.205217-1.75%
  • stellarStellar(XLM)$0.1787340.22%
  • Ethena USDeEthena USDe(USDE)$1.000.03%
  • bitcoin-cashBitcoin Cash(BCH)$228.181.22%
  • daiDai(DAI)$1.000.00%
  • USD1USD1(USD1)$1.000.05%
  • litecoinLitecoin(LTC)$53.422.41%
  • CantonCanton(CC)$0.098264-0.55%
  • uniswapUniswap(UNI)$6.070.68%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.361.04%
  • nearNEAR Protocol(NEAR)$2.583.19%
  • avalanche-2Avalanche(AVAX)$7.49-1.27%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • hedera-hashgraphHedera(HBAR)$0.074283-1.21%
  • shiba-inuShiba Inu(SHIB)$0.0000052.23%
  • suiSui(SUI)$0.73-1.29%
  • paypal-usdPayPal USD(PYUSD)$1.000.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • crypto-com-chainCronos(CRO)$0.0565380.71%
  • tether-goldTether Gold(XAUT)$4,347.670.09%
  • MemeCoreMemeCore(M)$1.170.93%
  • Circle USYCCircle USYC(USYC)$1.140.03%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • okbOKB(OKB)$113.271.92%
  • BittensorBittensor(TAO)$235.98-1.58%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.14-0.22%
  • mantleMantle(MNT)$0.593.00%
  • aaveAave(AAVE)$124.731.94%
  • pax-goldPAX Gold(PAXG)$4,352.200.16%
  • AsterAster(ASTER)$0.69-2.32%
  • polkadotPolkadot(DOT)$1.05-4.39%
  • OndoOndo(ONDO)$0.3535281.59%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Oppenheimer Holdings Inc. (OPY) Shareholder/Analyst Call Transcript

May 5, 2026
in Market & News
Reading Time: 2 mins read
A A
Oppenheimer Holdings Inc. (OPY) Shareholder/Analyst Call Transcript
ShareShareShareShareShare

Operator

Hello, and welcome to the Annual Meeting of Stockholders of Oppenheimer Holdings, Inc. [Operator Instructions] It is now my pleasure to turn today’s meeting over to Albert Lowenthal, Chairman of Oppenheimer Holdings, Inc.

YOU MAY ALSO LIKE

Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript

Saudi Arabian oil pipeline system hit by projectiles triggering fires – CNN

Mr. Lowenthal, the floor is yours.

Albert G. Lowenthal

Good afternoon, ladies and gentlemen. I want to welcome you to the 2026 Annual Meeting of Oppenheimer Holdings, Inc. This meeting is again being held virtually. I am Bud Lowenthal, and I will be chairing the meeting. It is now 4:30 p.m., and I would ask that the meeting come to order. I ask Mr. Dennis McNamara, the Secretary of the corporation, to act as Secretary of the meeting; Ms. Erica Ortiz-Indart of Computershare Shareholder Services, our transfer agent, to act as Inspector of Election. Ms. Ortiz Indart has executed an affidavit to execute her duties as the inspector faithfully. I direct that the secretary attach the affidavit to the minutes of this meeting.

The meeting will first address the formalities as described in our recent proxy statement. We have posted to our virtual meeting site a copy of our recent proxy statement and our annual report for the 2025 fiscal year, consisting of the annual report and the SEC Form 10-K. And I hope that each of you had an opportunity to review them. First order of business today will be to address the meeting’s formalities, after which our CEO, Robert Lowenthal, will make a presentation and answer questions.

Notice calling this meeting, together with the proxy statement was mailed to stockholders on March 17, 2026. I have before

Credit: Source link

ShareTweetSendSharePin

Related Posts

Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript
Market & News

Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript

September 11, 2026
Saudi Arabian oil pipeline system hit by projectiles triggering fires – CNN
Market & News

Saudi Arabian oil pipeline system hit by projectiles triggering fires – CNN

September 11, 2026
9/11 anniversary: Victims remembered 25 years on from attacks – follow live – BBC
Market & News

9/11 anniversary: Victims remembered 25 years on from attacks – follow live – BBC

September 11, 2026
Aya Gold & Silver: Updated PEA Brings Good News To An Already Solid Growth Stock (AYA)
Market & News

Aya Gold & Silver: Updated PEA Brings Good News To An Already Solid Growth Stock (AYA)

September 11, 2026
Next Post
Live Updates: U.S. sinks 7 small Iranian boats as Iran launches attacks on UAE and ships in Strait of Hormuz – CBS News

Live Updates: U.S. sinks 7 small Iranian boats as Iran launches attacks on UAE and ships in Strait of Hormuz - CBS News

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Watches, warnings discontinued as Hurricane Lowell pulls away from Hawaii – Hawaii News Now

Watches, warnings discontinued as Hurricane Lowell pulls away from Hawaii – Hawaii News Now

September 8, 2026
Buy 3 Ideal September Dividend Dogs Out Of Barron’s 58 August Picks

Buy 3 Ideal September Dividend Dogs Out Of Barron’s 58 August Picks

September 5, 2026
Definium Therapeutics, Inc. (DFTX) Discusses Phase III Clinical Progress and Study Outcomes for Lead Program in Mood Disorders Transcript

Definium Therapeutics, Inc. (DFTX) Discusses Phase III Clinical Progress and Study Outcomes for Lead Program in Mood Disorders Transcript

September 4, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!